83.14
+3.31
+(4.15%)
As of 2:11:30 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 6 | 8 | 8 |
| Avg. Estimate | 1.29 | 1.05 | 4.51 | 4.79 |
| Low Estimate | 1.24 | 0.96 | 4.5 | 4.75 |
| High Estimate | 1.3 | 1.12 | 4.54 | 4.84 |
| Year Ago EPS | 1.02 | 0.9 | 4.21 | 4.51 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 5 | 8 | 8 |
| Avg. Estimate | 289.36M | 275.87M | 1.13B | 1.16B |
| Low Estimate | 288M | 270.71M | 1.13B | 1.15B |
| High Estimate | 290.29M | 282.1M | 1.13B | 1.16B |
| Year Ago Sales | 276.99M | 267.14M | 1.13B | 1.13B |
| Sales Growth (year/est) | 4.47% | 3.27% | 0.47% | 2.25% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | 1.14 | 0.86 | 1.08 | 1.16 |
| EPS Actual | 1.02 | 0.9 | 1.09 | 1.22 |
| Difference | -0.12 | 0.04 | 0.01 | 0.06 |
| Surprise % | -10.53% | 4.65% | 0.53% | 5.43% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 1.29 | 1.05 | 4.51 | 4.79 |
| 7 Days Ago | 1.29 | 1.05 | 4.5 | 4.79 |
| 30 Days Ago | 1.29 | 1.05 | 4.5 | 4.79 |
| 60 Days Ago | 1.3 | 1.05 | 4.51 | 4.79 |
| 90 Days Ago | 1.3 | 1.07 | 4.44 | 4.77 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 4 | -- | 8 | 4 |
| Up Last 30 Days | 4 | -- | 8 | 4 |
| Down Last 7 Days | 2 | 1 | -- | 2 |
| Down Last 30 Days | 2 | 1 | -- | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PBH | 26.59% | 16.85% | 7.01% | 6.24% |
| S&P 500 | 6.52% | 6.29% | 9.55% | 14.25% |
Upgrades & Downgrades
| Maintains | RBC Capital: Sector Perform to Sector Perform | 3/21/2025 |
| Maintains | Oppenheimer: Outperform to Outperform | 2/13/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 2/7/2025 |
| Maintains | DA Davidson: Buy to Buy | 2/7/2025 |
| Maintains | DA Davidson: Buy to Buy | 11/11/2024 |
| Maintains | DA Davidson: Buy to Buy | 8/28/2024 |
Related Tickers
LNTH Lantheus Holdings, Inc.
100.02
+7.08%
BROOKS.NS Brooks Laboratories Limited
123.80
+0.15%
PRGO Perrigo Company plc
25.48
+3.79%
MKGAF Merck KGaA
121.95
-9.69%
ALKS Alkermes plc
28.60
+1.45%
LABB.MX Genomma Lab Internacional, S.A.B. de C.V.
22.80
+1.02%
HLN Haleon plc
9.60
+2.62%
GALDz.XC
AMPH Amphastar Pharmaceuticals, Inc.
25.33
+6.65%
RDY Dr. Reddy's Laboratories Limited
12.75
+2.57%